VulnerabilityAnalyzed
CVE-2026-24165
NVIDIA BioNeMo contains a vulnerability where a user could cause a deserialization of untrusted data.
HIGH 8.8EPSS 0.31%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.31%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
NVIDIA BioNeMo contains a vulnerability where a user could cause a deserialization of untrusted data. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.
- CVSS 3.1
- 8.8 HIGHCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 0.31% probability · 24th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-502
- Affected
- nvidia/bionemo framework
- Source
- psirt@nvidia.com
References
- https://nvd.nist.gov/vuln/detail/CVE-2026-24165Third Party Advisory, US Government Resource
- https://nvidia.custhelp.com/app/answers/detail/a_id/5808Vendor Advisory
- https://www.cve.org/CVERecord?id=CVE-2026-24165Third Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.